2022
Serum biomarkers associated with SARS-CoV-2 severity
de Morais Batista F, Puga M, da Silva P, Oliveira R, dos Santos P, da Silva B, Tatara M, Tsuha D, dos Santos Pires M, Gonçalves C, Pessoa e Silva R, Ferreira N, de Barros Albuquerque A, da Silva Duarte G, Consolaro M, Negrão F, Ferrari I, de Goes Cavalcanti L, Trinta K, Ribeiro G, de Melo Rêgo M, Boyton R, Siqueira A, Altmann D, Croda J. Serum biomarkers associated with SARS-CoV-2 severity. Scientific Reports 2022, 12: 15999. PMID: 36163447, PMCID: PMC9511452, DOI: 10.1038/s41598-022-20062-5.Peer-Reviewed Original ResearchConceptsSARS-CoV-2 infectionSevere casesSARS-CoV-2 severityCytokine/chemokine productionImmune response profileBiological marker levelsSARS-CoV-2GDF-15Clinical courseAcute phaseChemokine productionD-dimerSICAM-1Marker levelsSerum biomarkersHeart diseasePrognostic markerCardiovascular diseaseGroup C.Angiogenesis markersGroup SPrognostic signatureGroup MP-selectinDisease severity
2021
Risk Factors for Death Among 120,804 Hospitalized Patients with Confirmed COVID-19 in São Paulo, Brazil
da Silva P, de Oliveira S, Escalante J, Almiron M, Tsuha D, Sato H, Menezes P, de Paula R, D’Agostini T, Croda J. Risk Factors for Death Among 120,804 Hospitalized Patients with Confirmed COVID-19 in São Paulo, Brazil. American Journal Of Tropical Medicine And Hygiene 2021, 105: 88-92. PMID: 34061773, PMCID: PMC8274770, DOI: 10.4269/ajtmh.20-1598.Peer-Reviewed Original ResearchConceptsCOVID-19Confirmed COVID-19Characteristics of patientsChronic lung diseaseIntensive care unitChronic cardiovascular diseaseChronic neurological diseaseMore comorbiditiesClinical characteristicsDiabetes mellitusMedian ageCare unitLung diseaseRisk factorsCardiovascular diseaseHigh riskSevere casesElderly individualsPatientsNeurological diseasesSurvival analysisCoronavirus diseaseDiseaseSão PauloDeath